Janux Therapeutics, Inc. (NASDAQ:JANX) filed a Form 8-K with the Securities and Exchange Commission on January 22, 2026, disclosing a material event.
Janux Therapeutics, Inc.'s stock currently trades at $15.14 with a market capitalization of $922.7M. The Healthcare company's stock moved following the disclosure.